PT  - JOURNAL ARTICLE
AU  - Cho, Byoung Chul
AU  - Lee, Jae Lyun
AU  - Shin, Sang Joon
AU  - Shim, Byoung Yong
AU  - Lee, Hyo Jin
AU  - Lee, Jung-Yun
AU  - Powderly, John
AU  - Lee, Soohyeon
AU  - Cohen, Julia
AU  - Yun, Nari
AU  - Ham, Mina
AU  - Lee, Kyoyoung
AU  - Kang, Hyunjin
AU  - Pyo, Kyoung-Ho
AU  - Kim, Jea Hwan
AU  - Kim, Mi hyun
AU  - Kim, Dong
AU  - Jang, Myoung Ho
TI  - 710 Keynote-B59: dose escalation of a phase 1/2 first-in-human, open-label study of GI-101, a novel immunocytokine combining CD80-IL2v, in combination with pembrolizumab in advanced solid tumors
AID  - 10.1136/jitc-2023-SITC2023.0710
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A805--A805
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A805.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A805.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.